In the intensive lipid-lowering group, LDL-cholesterol was reduced by 49%, achieving a median level of 62 mg/dL (1.6 mmol/L) during follow-up, compared with a 21% reduction in the standard therapy ...
Ezetimibe/simvastatin: 10/10 mg, 10/20 mg, 10/40 mg, and 10/80 mg. Atorvastatin: 10 mg, 20 mg, 40 mg, and 80 mg. The primary end point of the study was the percent change from baseline to the end of ...
NEW ORLEANS, LA—Hospitalizations for congestive heart failure (CHF) occurred more frequently among patients with lower baseline and 1-year estimated glomerular filtration rates (eGFR), according to ...
Pfizer announced that in patients with established heart disease, Lipitor® (atorvastatin calcium) 80 mg not only significantly reduced the relative risk of suffering a first cardiovascular event by 19 ...
In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well.more Lipitor (atorvastatin) and Crestor (rosuvastatin) both ...
NEW YORK--(BUSINESS WIRE)--Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Lipitor® (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, ...
Patients taking Lipitor (atorvastatin calcium) 80 mg who had a prior stroke reduced their risk of an additional stroke by 16% and major coronary events, such as heart attack, cardiac death or ...
Objective: Patient switching of prescription drug brands within a therapeutic class has become more prevalent with tiered drug plan formularies. Although switching from more expensive brand name drugs ...
To examine the mechanisms underlying the effects of atorvastatin on glucose and lipid metabolism. Mice with insulin resistance and obesity induced by monosodium glutamate (MSG) were used. Atorvastatin ...
More than 140,000 bottles of atorvastatin calcium tablets, a generic version of the cholesterol-lowering drug Lipitor, have been recalled due to "failed dissolution specifications," the U.S. Food and ...
Press Release: Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease NEW YORK, March 7 -- Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results